Relative Vaccine Effectiveness of Adjuvanted Trivalent Influenza Vaccine over Three Consecutive Influenza Seasons in the United States

Traditional influenza vaccines may be less immunogenic in adults ≥65 years of age due to immunosenescence. Two influenza vaccines—MF59®-adjuvanted trivalent inactivated influenza vaccine (aIIV3) and high-dose influenza vaccine (HD-IIV3)—were developed to overcome this problem. We summarize estimates...

Descripción completa

Detalles Bibliográficos
Autores principales: Boikos, Constantina, McGovern, Ian, Ortiz, Justin R., Puig-Barberà, Joan, Versage, Eve, Haag, Mendel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504704/
https://www.ncbi.nlm.nih.gov/pubmed/36146534
http://dx.doi.org/10.3390/vaccines10091456

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504704/
https://www.ncbi.nlm.nih.gov/pubmed/36146534
http://dx.doi.org/10.3390/vaccines10091456

Ejemplares similares